Researchers value this dual–GHSR agonist composition because it enables comparative and combined analysis of two growth hormone secretagogues with distinct receptor interaction profiles. GHRP-6 is frequently studied for its strong GH-release characteristics and ghrelin-mimetic signaling effects. GHRP-2 offers a more selective receptor influence with reduced off-target endocrine responses, making it useful for differential pathway assessment.

Common research applications include:

• Evaluating receptor-specific activation differences between GHRP-6 and GHRP-2

• Investigating GH-pulse amplitude and timing in vitro or ex vivo

• Studying synergistic or additive effects in pituitary signaling

• Comparing multi-peptide stimulation with isolated control conditions

Both peptides show consistent activity in controlled research settings, supporting structured mechanistic experiments and precise dose–response analysis. This combination is well suited for advanced endocrine studies requiring traceable inputs and clearly measurable outcomes.

This product is intended exclusively for scientific research. It is not approved for therapeutic, diagnostic, veterinary, or clinical use. All laboratory handling must follow appropriate safety procedures and regulatory compliance.

For research use only. Not for human consumption.

This GHRP-6 + GHRP-2 peptide blend contains 5 mg of GHRP-6 and 10 mg of GHRP-2, enabling controlled studies on receptor-specific activation and GH-axis modulation.